TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
RexCell Tissue & Airlaid AB
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 1,234,694 | 815,077 | 802,555 |
Financial expenses | 475 | 384 | 1,240 |
Earnings before taxes | 225,578 | 78,016 | 112,257 |
EBITDA | 252,989 | 109,802 | 150,758 |
Total assets | 634,639 | 586,516 | 561,411 |
Current assets | 378,714 | 315,780 | 254,163 |
Current liabilities | 268,975 | 218,858 | 160,305 |
Equity capital | 304,118 | 305,433 | 331,797 |
- share capital | 1,135 | 1,170 | 1,257 |
Employees (average) | 194 | 190 | 186 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 47.9% | 52.1% | 59.1% |
Turnover per employee | 6,364 | 4,290 | 4,315 |
Profit as a percentage of turnover | 18.3% | 9.6% | 14.0% |
Return on assets (ROA) | 35.6% | 13.4% | 20.2% |
Current ratio | 140.8% | 144.3% | 158.5% |
Return on equity (ROE) | 74.2% | 25.5% | 33.8% |
Change turnover | 444,114 | 67,971 | -347,853 |
Change turnover % | 56% | 9% | -30% |
Chg. No. of employees | 4 | 4 | -5 |
Chg. No. of employees % | 2% | 2% | -3% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.